Luminist Labs YC Demo Day (W16) - Diagnostic platform for early detection of liver disease
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
![[500 STARTUPS DEMO DAY 2017] BATCH 19, Mojilala](https://img.youtube.com/vi/Bhcbf-Tp_io/0.jpg)
![[500 STARTUPS DEMO DAY 2017] BATCH 19, Almabase](https://img.youtube.com/vi/ZPvFMo-hjrs/0.jpg)
![Antler SEA Demo Day May 2022 [Live]](https://img.youtube.com/vi/h28AXg2S_Lk/0.jpg)